Related Experiment Video
Updated: Aug 3, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Communicating about the flare-up and its treatment]
1Service neurologie, centre hospitalier universitaire de Rennes, 2 rue Henri-le-Guilloux, 35000 Rennes, France; Association Neuro-Bretagne, centre hospitalier universitaire de Rennes, 2 rue Henri-le-Guilloux, 35000 Rennes, France.
Abstract:
Relapsing-remitting multiple sclerosis progresses by relapse. It is therefore necessary to know how to identify this phenomenon in order to be able to provide the best possible support to patients. The term "relapse" is used to characterize the period of a few days to a few weeks during which an attack of inflammation of the myelin occurs. Depending on the area affected, the symptoms will be different. To qualify as a relapse, the patient must have had new, permanent symptoms for at least 24 hours without fever or signs of infection and within 30 days of the last relapse.
Insights
Identifying relapsing-remitting multiple sclerosis relapses is crucial for patient support. A relapse involves new, lasting neurological symptoms for over 24 hours, excluding fever or infection, within 30 days of the prior event.
Area of Science:
- Neuroimmunology
- Clinical Neurology
Context:
- Relapsing-remitting multiple sclerosis (RRMS) is characterized by distinct episodes of neurological dysfunction.
- Accurate identification of these episodes is essential for effective patient management and treatment strategies.
Purpose:
- To define the diagnostic criteria for a multiple sclerosis relapse.
- To provide clear guidelines for healthcare professionals in identifying relapse events.
Summary:
- A multiple sclerosis relapse is defined as new neurological symptoms lasting at least 24 hours.
- These symptoms must be permanent, without fever or infection, and occur within 30 days of a previous relapse.
- Symptom presentation varies based on the affected area of the central nervous system.
Impact:
- Facilitates timely and appropriate clinical interventions for patients experiencing relapses.
- Improves the consistency of relapse diagnosis across different healthcare settings.
- Supports research into the mechanisms and management of multiple sclerosis progression.
More Related Videos
04:50Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Techniques of Therapeutic Communication II: Focusing, Paraphrasing, and Summarizing
This therapeutic technique can also be used when a patient brings up pertinent information during a health-related conversation. The...